Coffee consumption and the risk of cutaneous melanoma: a meta-analysis
- 574 Downloads
Results from epidemiologic studies on coffee consumption and the risk of cutaneous melanoma are inconsistent. We conducted a meta-analysis to assess the associations between the consumption of total coffee, caffeinated coffee and decaffeinated coffee and the risk of cutaneous melanoma, respectively.
A literature search was performed in PubMed, Web of Science and EMBASE for relevant articles published up to August 2015. Pooled relative risks (RRs) with 95 % confidence intervals (CIs) were calculated with a random-effects model. Dose–response relationship was assessed by restricted cubic spline.
Twelve studies involving 832,956 participants for total coffee consumption, 5 studies involving 717,151 participants for caffeinated coffee consumption and 6 studies involving 718,231 participants for decaffeinated coffee consumption were included in this meta-analysis. Compared with the lowest level of consumption, the pooled RRs were 0.80 (95 % CI 0.69–0.93, I 2 = 53.5 %), 0.85 (95 % CI 0.71–1.01, I 2 = 65.0 %) and 0.92 (95 % CI 0.81–1.05, I 2 = 0.0 %) for the consumption of total coffee, caffeinated coffee and decaffeinated coffee, respectively. In subgroup analysis by study design, the pooled RRs in cohort studies and case–control studies were 0.83 (95 % CI 0.72–0.97) and 0.74 (95 % CI 0.51–1.07) for total coffee consumption, respectively. Dose–response analysis suggested cutaneous melanoma risk decreased by 3 % [0.97 (0.93–1.00)] and 4 % [0.96 (0.92–1.01)] for 1 cup/day increment of total coffee and caffeinated coffee consumption, respectively.
This meta-analysis suggests that coffee consumption may reduce the risk of cutaneous melanoma.
KeywordsCoffee Caffeinated coffee Cutaneous melanoma Meta-analysis
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 2.Leiter U, Eigentler T, Garbe C (2014) Epidemiology of skin cancer. Adv Exp Med Biol 810:120–140Google Scholar
- 3.SEER Stat Fact Sheets: Melanoma of the skin (2015). http://seer.cancer.gov/statfacts/html/melan.html
- 13.Fortes C, Mastroeni S, Boffetta P, Antonelli G, Pilla MA, Botta G, Anzidei P, Venanzetti F (2013) The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms. Cancer Causes Control 24(10):1779–1787. doi: 10.1007/s10552-013-0255-4 CrossRefGoogle Scholar
- 30.Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 47:15–17Google Scholar
- 34.Orsini N, Bellocco R (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata J 6:40–57Google Scholar
- 37.Lu YP, Lou YR, Xie JG, Peng QY, Zhou S, Lin Y, Shih WJ, Conney AH (2007) Caffeine and caffeine sodium benzoate have a sunscreen effect, enhance UVB-induced apoptosis, and inhibit UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 28(1):199–206. doi: 10.1093/carcin/bgl112 CrossRefGoogle Scholar
- 38.Gude RP, Menon LG, Rao SG (2001) Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. J Exp Clin Cancer Res 20(2):287–292Google Scholar
- 40.Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61(1):303–308Google Scholar
- 48.IARC Working Group (1991) Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum 51:1–513Google Scholar